Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MOUNTAIN CREST ACQUISITION CORP. V

(MCAG)
Delayed Nasdaq  -  09:56 2022-11-25 am EST
10.01 USD   +0.17%
11/16Mountain Crest Acquisition Corp. V : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
11/15AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II Clinical Trial of AUM001 for Treatment of Metastatic Colorectal Cancer in Australia
AQ
11/07MOUNTAIN CREST ACQUISITION CORP. V Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Mountain Crest Acquisition Corp. V Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

08/12/2022 | 05:01pm EST

Mountain Crest Acquisition Corp. V reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 0.041213 million compared to USD 0.001 million a year ago.
For the six months, net loss was USD 0.163093 million.


ę S&P Capital IQ 2022
Stocks mentioned in the article
ChangeLast1st jan.
MOUNTAIN CREST ACQUISITION CORP. V 0.17% 10.007 Delayed Quote.2.53%
PAX DOLLAR (USDP/USD) 0.04% 0.9997 End-of-day quote.-0.02%
All news about MOUNTAIN CREST ACQUISITION CORP. V
11/16Mountain Crest Acquisition Corp. V : Regulation FD Disclosure, Financial Statements and Ex..
AQ
11/15AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II ..
AQ
11/07MOUNTAIN CREST ACQUISITION CORP. V Management's Discussion and Analysis of Financial C..
AQ
11/07Mountain Crest Acquisition Corp. V Reports Earnings Results for the Third Quarter and N..
CI
11/04AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit
AQ
10/21Insider Sell: Mountain Crest Acquisition Corp. V
MT
10/20Mountain Crest Acquisition Corp. V : Entry into a Material Definitive Agreement, Regulatio..
AQ
10/20Mountain Crest Acquisition to Merge With AUM Biosciences
MT
10/20AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeut..
AQ
10/20AUM Biosciences Pte. Ltd. entered into a definitive business combination agreement to a..
CI
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -0,20 M - -
Net cash 2021 0,47 M - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 90,3 M 90,3 M -
EV / Sales 2020
EV / Sales 2021 -
Nbr of Employees -
Free-Float 79,5%
Chart MOUNTAIN CREST ACQUISITION CORP. V
Duration : Period :
Mountain Crest Acquisition Corp. V Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Su Ying Liu Chairman, Chief Executive & Financial Officer
Nelson M. Haight Independent Director
Todd Milbourn Independent Director
Wen Hua Zhang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MOUNTAIN CREST ACQUISITION CORP. V2.53%90
INVESTOR AB (PUBL)-14.54%58 371
CK HUTCHISON HOLDINGS LIMITED-13.42%21 356
GROUPE BRUXELLES LAMBERT SA-19.38%11 731
HAL TRUST-12.28%11 534
AB INDUSTRIVÄRDEN (PUBL)-5.69%11 259